Systemic mastocytosis
Hodgkin’s lymphoma is a rare form of clonal haematological non-mast cell disease in systemic mastocytosis
... Case: We present a case of a 37-year-old otherwise healthy male who was referred to our institution because of a one-month lasting dysphagia of both hard and liquid food. Physical examination showed tumour in the left ...
5
Hypotension, Syncope, and Fever in Systemic Mastocytosis without Skin Infiltration and Rapid Response to Corticosteroid and Cyclosporin: A Case Report
... [2]. Mastocytosis limited to the skin is called cutaneous mastocytosis, and when extracutaneous organs such as bone marrow, liver, spleen, or gastrointestinal tract are involved, it is called ...
5
Case Report Systemic mastocytosis with associated myeloproliferative neoplasm with t(8;19)(p12;q13.1) and abnormality of FGFR1 : report of a unique case
... Systemic mastocytosis is a clonal neoplastic proliferation of mast cells involving multiple ...cells. Systemic mastocytosis associated with clonal hematological, non-mast cell lin- eage ...
7
Anaphylactic reaction to platelet transfusion as the initial symptom of an undiagnosed systemic mastocytosis: a case report and review of the literature
... Systemic mastocytosis (SM) is part of a spectrum of diseases which are characterized by the proliferation of neoplastic mast cells ...mediator-related systemic symp- ...cutaneous mastocytosis ...
5
Critical care management of systemic mastocytosis: when every wasp is a killer bee
... of systemic mastocytosis, recognition of this disease is of utmost importance in the critical care management of these ...patients. Mastocytosis is a severely under-recognized disease because it ...
5
www.ijcep.com /IJCEP1004001 Case Report Systemic mastocytosis in association with chronic lymphocytic leukemia and plasma cell myeloma
... [1]. Systemic mastocytosis (SM), a major subtype of mastocytosis according to the current WHO classification [2], is a heterogene- ous group of mast cell disorders involving at least one ...
10
A new humanized in vivo model of KIT D816V advanced systemic mastocytosis monitored using a secreted luciferase
... MCs in one or several organs, affecting both children and adults [6]. In adults, most patients present with a systemic involvement (systemic mastocytosis; SM). According to the World Health ...
16
European Medicines Agency review of midostaurin (Rydapt) for the treatment of adult patients with acute myeloid leukaemia and systemic mastocytosis
... aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated haematological neoplasm (SM- AHN) or mast cell leukaemia ...on mastocytosis) criteria of ...
10
Modelling of a genetically diverse evolution of Systemic Mastocytosis with Chronic Myelomonocytic Leukemia (SM-CMML) by Next Generation Sequencing
... RN: Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: clinical significance and comparison of chomosomal abnormalities in SM and AHNMD ...H: Systemic ...
6
An Adult Patient with Systemic Mastocytosis and B-Acute Lymphoblastic Leukemia
... cutaneous mastocytosis (CM), affecting solely the skin, and to systemic mastocytosis (SM), involving at least one extracutaneous organ with more severe clinical ...
6
Clinical potential of midostaurin in advanced systemic mastocytosis
... aggressive systemic mastocytosis; C, clinical; G, grade; MCL, mast cell leukemia; MCS, mast cell sarcoma; mTOR, mammalian target of rapamycin; na, not available; NA, not applicable; ORR, overall response ...
11
<p>Novel approaches to treating advanced systemic mastocytosis</p>
... Abstract: Mastocytosis is a myeloproliferative neoplasm characterized by expansion of abnormal mast cells (MCs) in various tissues, including skin, bone marrow, gastrointestinal tract, liver, spleen, or lymph ...
16
Systemic mastocytosis with KIT V560G mutation presenting as recurrent episodes of vascular collapse: response to disodium cromoglycate and disease outcome
... French Mastocytosis Network; APC: allophycocyanin; ASM: aggres‑ sive systemic mastocytosis; BD: Becton–Dickinson; BM: bone marrow; CM: cutaneous mastocytosis; DSCG: disodium cromoglycate; ...
10
Spotlight on midostaurin in the treatment of FLT3-mutated acute myeloid leukemia and systemic mastocytosis: design, development, and potential place in therapy
... taurin (PKC412), the FMS-like tyrosine kinase 3 receptor (FLT3) and multi-targeted kinase inhibitor, in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome [r] ...
8
The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis
... nonacute mastocytosis subjects, and binds with high affinity to recombinant beta-tryptase, tryptase in serum during anaphylaxis, and tryptase stored in mast cell secretory ...during systemic anaphylaxis in ...
10
Oral and inhaled sodium cromoglicate in the management of systemic mastocytosis: a case report
... After a while I finally went to see a doctor, this time I went to a dermatologist because of spots that I had all over my body which were itching terribly. I've had those spots since I was two years old but in my younger ...
6
The significance of diagnosing associated clonal mast cell diseases in patients with venom-induced anaphylaxis and the role of bone marrow investigation
... The term CMD comprises systemic mastocytosis (SM) and monoclonal mast cell activation syndrome (MMAS) [6-8]. The common finding in these two conditions is the mast cells clonality; which can be proven by ...
6
Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis
... into systemic mastocytosis and cutaneous mastocyto- sis according to the infiltrated ...of mastocytosis [37–39], and can be found in almost each region of KIT but are not randomly ...in ...
10
Etiology of Chinaberry Gall Disease in Iran
... reisolated. Systemic movement of the isolates into the vascular system of chinaberry was shown by the formation of gall above the inoculation site on the ...
8
Adrenergic control of the cardiovascular system in the turtle Trachemys scripta
... the systemic resistance is modulated with adrenergic mechanisms (as shown here), the consequences on the cardiac shunt patterns are the same because they are determined primarily by the ratios of the pulmonary and ...
11